Experimental induction of myelin changes by anti-MAG antibodies and terminal complement complex.
We investigated the role of anti-myelin-associated glycoprotein (MAG) IgM and complement (C) in the pathogenesis of myelin alterations occurring in patients with anti-MAG-associated polyneuropathy. For this purpose, we separately studied the effects of anti-MAG antibodies and terminal C complex (TCC) after injection into the rabbit sciatic nerve. The two different local treatments produced identical ultrastructural abnormalities such as intramyelinic edema, myelin vesiculation and, in particular, separation of the major dense lines with the formation of widely spaced myelin, a peculiar feature encountered in human peripheral nerve disorders with circulating anti-myelin monoclonal IgM. In nerves treated with anti-MAG IgM ultrastructural myelin alterations were concurrent with activation of the rabbit's own C to the formation of TCC. Contrary to the immunological and ultrastructural findings obtained in C-sufficient animals, in C6-deficient rabbits injected with anti-MAG IgM no myelin alterations nor C completion were observed. This study identifies anti-MAG IgM as the mediator and the C as the effector of myelin changes observed in the present model and, for extension, in human neuropathies associated with anti-MAG IgM.
Monaco
S
S
Dipartimento di Scienze Neurologiche e della Visione, University of Verona, Italy.
Ferrari
S
S
Bonetti
B
B
Moretto
G
G
Kirshfink
M
M
Nardelli
E
E
Nobile-Orazio
E
E
Zanusso
G
G
Rizzuto
N
N
Tedesco
F
F
D000818:Animals; D000906:Antibodies / Q000494:pharmacology*; D003183:Complement C6 / Q000172:deficiency; D015938:Complement Membrane Attack Complex / Q000494:pharmacology*; D006801:Humans; D007075:Immunoglobulin M / Q000276:immunology* / Q000494:pharmacology*; D007267:Injections; D009185:Myelin Proteins / Q000276:immunology*; D009186:Myelin Sheath / Q000187:drug effects* / Q000648:ultrastructure; D018992:Myelin-Associated Glycoprotein; D011817:Rabbits; D012016:Reference Values; D012584:Sciatic Nerve / Q000187:drug effects / Q000648:ultrastructure
D000906:Antibodies; D003183:Complement C6; D015938:Complement Membrane Attack Complex; D007075:Immunoglobulin M; D009185:Myelin Proteins; D018992:Myelin-Associated Glycoprotein